A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/46 (2006.01) A61P 11/00 (2006.01) A61P 11/06 (2006.01) A61P 11/08 (2006.01)
Patent
CA 2498911
The invention relates to a method for the reduction of the mortality rate in patients said method comprising the administration of a therapeutically effective amount of (1 ,2 ,4 ,5 ,7 )-7-~(hydroxydi-2-thienylacetyl)oxy~-9,9- dimethyl-3-oxa-9-azoniatricyclo~3.3.1.02,4~ nonane salts.
Cette invention a trait à une méthode permettant de réduire le taux de mortalité chez certains patients. Cette méthode consiste à leur administrer une quantité efficace du point de vue thérapeutique de sels de nonane (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta. )-7-Ý(hydroxydi-2-thienylacétyl)oxy¨-9,9-diméthyl-3-oxa-9-azoniatricycloÝ3.3.1.02,4¨.
Disse Bernd
Kesten Steven
Witek Theodore
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Boehringer Ingelheim Pharmaceuticals Inc.
Fetherstonhaugh & Co.
LandOfFree
Tiotropium salts for reducing respiratory mortality rate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tiotropium salts for reducing respiratory mortality rate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tiotropium salts for reducing respiratory mortality rate will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1371702